Caroverine in tinnitus treatment: A placebo-controlled blind study

Acta Oto-Laryngologica

Volumn 117, Issue 6, 1997, Pages 825-830

  Denk, Doris Maria ^a   Heinzl, Harald ^a   Franz, Peter ^a   Ehrenberger, Klaus ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Caroverine; Cochlear synaptic tinnitus; Tinnitus therapy; Transmitter antagonists

Indexed keywords

CAROVERINE; PLACEBO;

ACOUSTICS; ADULT; AGED; ARTICLE; AUDITORY SYSTEM; CLINICAL TRIAL; COMPETITIVE INHIBITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HAIR CELL; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROIONTOPHORESIS; NEUROTRANSMITTER RELEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RATING SCALE; SYNAPTIC TRANSMISSION; TINNITUS;

EID: 0030667713     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.3109/00016489709114208     Document Type: Article

References (21)

1. Ehrenberger K, Brix R. Glutamic acid and glutamic acid diethyl ester in tinnitus treatment. Acta Otolaryngol (Stockh) 1983; 95: 599-605.
2. Eggermont JJ. On the pathophysiology of tinnitus: A review and peripheral model. Hear Res 1990; 48: 111 - 24.
3. Eybalin M, Pujol R. Cochlear neuroactive substances. Arch Otorhinolaryngol 1989; 246: 228-34.
4. Felix D, Ehrenberger K. A microiontophoretic study of the role of excitatory amino acids at the afferent synapses of mammalian inner hair cells. Eur Arch Otorhinolaryngol 1990; 248: 1-3.
5. Ehrenberger K. Felix D. Glutamate receptors in afferent cochlear neurotransmission in guinea pigs. Hear Res 1991; 52: 73-80.
6. Eybalin M. Neurotransmitters and neuromodulators of the mammalian cochlea. Physiol Rev 1993; 73: 309-73.
7. Pujol R, Puel JL, Gervais d'Aldin C, Eybalin M. Pathophysiology of the glutamatergic synapses in the cochlea. Acta Otolaryngol (Stockh) 1993; 113: 330-4.
8. Ehrenberger K, Felix D. Receptor pharmacological models for inner ear therapies with emphasis on glutamate receptor: A survey. Acta Otolaryngol (Stockh) 1995; 115: 236-40.
9. Denk D-M, Brix R, Felix D, Ehrenberger K. Tinnitus therapy with transmitters. In: Aran JM, Dauman R, eds. Tinnitus 91. Amsterdam: Kugler, 1992; 119-21.
10. Tonndorf J. Stereociliary dysfunction, a cause of sensory hearing loss, recruitment, poor speech discrimination and tinnitus. Acta Otolaryngol 1991; 91: 469-71.
11. Denk D-M, Felix D, Ehrenberger K. Caroverine for therapy of cochlear-synaptic tinnitus. In: Proceedings of Inner Ear Neuropharmacology, Montpellier, 1994.
12. Ehrenberger K, Denk DM, Felix D. Rezeptorphar-makologische Modelle für eine kausale Tinnitustherapie (Receptor pharmacological models for a causal tinnitus therapy). Oto-Rhino-Laryngol Nova 1995; 5: 148-52.
13. Ehrenberger K, Felix D. Caroverine depresses the activity of cochlear glutamate receptors in guinea pigs: In vivo model for drug-induced neuroprotection. Neuropharmacology 1992; 31: 1259-63.
14. Cameron JR, Skafronick JG. Medical physics. New York: Wiley & Sons, 1978.
15. StatXact-Turbo: Statistical software for exact nonparametric inference. Cambridge, MA: Cytel Software Corporation, 1992.
16. Møller AR, Tinnitus. In: Jackler RK, Brackmann D, eds. Neurootology. St. Louis: Mosby Year Book, 1994; 153-65.
17. Murai K, Tyler RS, Harker LA, Stouffer JL. Review of pharmacologic treatment of tinnitus. Am J Otol 1992; 13: 454-64.
18. Paaske PB, Pedersen CB, Kjems G, Sam IL. Zinc in the managemant of tinnitus. Placebo-controlled trial. Ann Otol Rhinol Laryngol 1991; 100: 647-9.
19. Lipton SA. Prospects for clinically tolerated NMDA antagonists: Open channel blockers and alternative redox states of nitric oxide. Trends Neurosci 1993; 16: 527-32.
20. Heiniger-Bürki CB, Ehrenberger K, Felix D. Is nitric-oxide involved in inner ear neurotransmission? Prim Sensory Neuron 1995; 1: 41-6.
21. Franz P, Hauser Kronberger C, Böck P, Quint C, Baumgartner W. Localization of nitric oxide synthase I and III in the cochlea. Acta Otolaryngol (Stockh) 1996; 116: 726-31.